—
C+
C+ The full Closelook — membership. Open the C+ overview

Bio-Rad Laboratories Inc (BIO) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Bio-Rad Laboratories Inc

BIO in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Bio-Rad supplies tools for life-science research and for clinical diagnostics, organised into two segments. The Life Science side sells instruments, reagents and consumables that separate, purify and analyse cells, proteins and nucleic acids for laboratories, biopharma manufacturers and food-safety testers. The Clinical Diagnostics side sells test systems, test kits, informatics and quality controls used in hospital, reference and transfusion laboratories. It reaches customers directly and through distributors, and is based in Hercules, California.
Where it sits in the stack
Bio-Rad carries no seat in our Rubin index for the AI build-out, so it sits instead in the medical-devices sleeve of our wider universe, alongside other life-science tools and diagnostics suppliers.
Who it is priced against
The diary has not set a Closelook peer group for this name; the comparison the market usually draws is with Thermo Fisher Scientific, another supplier of life-science tools and diagnostics equipment of similar breadth.
Why Closelook tracks it
Bio-Rad holds a Russell 1000 seat but no Rubin seat and no Closelook score yet. It has appeared once in the diary, cited in a Midday 10 note that grouped it among health-care and biotech names making new highs alongside a broader ex-tech breadth thesis.
What the diary watches
Whether Bio-Rad keeps showing up on broad health-care new-high lists as a sign of sector-wide breadth, or whether its diagnostics and life-science segments start to diverge in trend.

Bio-Rad Laboratories Inc (BIO) trades on US exchanges.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for BIO, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against Medical Devices · United States · 8 names with week and year-to-date

Peer group

Medical Devices · United States

This name carries no Closelook score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against BIO on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 55/100 · S&P 500 fund at 58, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-17
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +2.7% over 20 sessions. Factor regime → 2026-09-17
  • Sovereign pressure Index 0.00 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-17

FAQ · from the current data · as of 2026-09-18

Quick answers

What is Bio-Rad Laboratories Inc (BIO)?

Bio-Rad Laboratories Inc trades as BIO on the US exchange (United States) in the Closelook research universe, as of the registry build of 2026-09-18.

Is BIO in a Closelook index?

Not currently — Bio-Rad Laboratories Inc is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-18.

Where does BIO trade against its moving averages?

Uptrend stack intact: Trades +9.5% vs the 50-day and +25.7% vs the 200-day average, 3.5% below the 52-week high and +61.5% off the 52-week low; a golden cross printed 37 sessions ago. Computed from daily closes. As of 2026-09-17 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Bio-Rad Laboratories Inc do?

Bio-Rad supplies tools for life-science research and for clinical diagnostics, organised into two segments. The Life Science side sells instruments, reagents and consumables that separate, purify and analyse cells, proteins and nucleic acids for laboratories, biopharma manufacturers and food-safety testers. The Clinical Diagnostics side sells test systems, test kits, informatics and quality controls used in hospital, reference and transfusion laboratories. The diary has not set a Closelook peer group for this name; the comparison the market usually draws is with Thermo Fisher Scientific, another supplier of life-science tools and diagnostics equipment of similar breadth.

Where does Bio-Rad Laboratories Inc sit in the AI build-out?

Bio-Rad carries no seat in our Rubin index for the AI build-out, so it sits instead in the medical-devices sleeve of our wider universe, alongside other life-science tools and diagnostics suppliers. Bio-Rad holds a Russell 1000 seat but no Rubin seat and no Closelook score yet. It has appeared once in the diary, cited in a Midday 10 note that grouped it among health-care and biotech names making new highs alongside a broader ex-tech breadth thesis.

Where has Closelook written about Bio-Rad Laboratories Inc?

Bio-Rad Laboratories Inc appears in 1 Closelook piece, most recently Midday 10: A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000 (2026-08-21). What Closelook said most recently: Barchart's large-cap 52-week new-high list, as of 11:59 CDT, carries 31 names and reads like the ex-tech thesis printed as breadth: twelve are health care, biotech or pharma — ARGX, BDX, BIO, CORT, HALO, MRK, REGN, RVTY, THC, TVTX, TXG… (Midday 10, 2026-08-21). The "Mentioned on Closelook" block on this page lists the long reads, the reference entries and the dailies that name it.

What does this page show?

A live price chart with SMA overlays and drawing tools for BIO, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Mentioned on Closelook 1 piece · newest: Midday 10, “A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000” (2026-08-21)

Mentioned on Closelook

Where BIO appears in the diary — 1 piece, newest first. Every link is our own writing.

Dailies

Related in the Closelook universe

then Medical Devices. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.